Technical Analysis for KYMR - Kymera Therapeutics, Inc.

Grade Last Price % Change Price Change
D 36.18 3.51% 1.23
KYMR closed down 1.83 percent on Friday, May 17, 2024, on 83 percent of normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 3.51%
MACD Bearish Signal Line Cross Bearish 3.51%
20 DMA Resistance Bearish 0.65%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.65%
Inside Day Range Contraction 0.65%
Gapped Up Strength 0.65%
Bearish Engulfing Bearish 3.09%
Fell Below 20 DMA Bearish 3.09%
Fell Below 50 DMA Bearish 3.09%
Expansion Pivot Sell Setup Bearish Swing Setup 3.09%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout 10 minutes ago
Up 3% 27 minutes ago
Rose Above Previous Day's High 40 minutes ago
Up 2% 40 minutes ago
Up 1% about 1 hour ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Immunology Solid Tumors Immune System Autoimmune Disease Autoimmunity Rheumatoid Arthritis Hematologic Malignancies Atopic Dermatitis Dermatitis Hidradenitis Suppurativa

Is KYMR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 45.31
52 Week Low 9.6
Average Volume 590,700
200-Day Moving Average 26.75
50-Day Moving Average 37.44
20-Day Moving Average 36.10
10-Day Moving Average 37.17
Average True Range 1.84
RSI (14) 43.50
ADX 21.87
+DI 16.78
-DI 24.60
Chandelier Exit (Long, 3 ATRs) 34.12
Chandelier Exit (Short, 3 ATRs) 38.26
Upper Bollinger Bands 39.63
Lower Bollinger Band 32.56
Percent B (%b) 0.34
BandWidth 19.56
MACD Line -0.13
MACD Signal Line -0.03
MACD Histogram -0.0963
Fundamentals Value
Market Cap 2.08 Billion
Num Shares 59.4 Million
EPS -2.86
Price-to-Earnings (P/E) Ratio -12.22
Price-to-Sales 46.41
Price-to-Book 5.59
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 36.71
Resistance 3 (R3) 36.76 36.22 36.41
Resistance 2 (R2) 36.22 35.78 36.20 36.31
Resistance 1 (R1) 35.59 35.50 35.32 35.54 36.22
Pivot Point 35.05 35.05 34.92 35.03 35.05
Support 1 (S1) 34.42 34.61 34.15 34.37 33.68
Support 2 (S2) 33.88 34.33 33.86 33.59
Support 3 (S3) 33.25 33.88 33.49
Support 4 (S4) 33.20